Northwestern Mutual Wealth Management’s Xenon Pharmaceuticals XENE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302K	Hold	5,000	–	–	﹤0.01%	1830
2026 Q1	$291K	Hold	5,000	–	–	﹤0.01%	1753
2025 Q4	$224K	Hold	5,000	–	–	﹤0.01%	1815
2025 Q3	$201K	Hold	5,000	–	–	﹤0.01%	1794
2025 Q2	$157K	Hold	5,000	–	–	﹤0.01%	1843
2025 Q1	$168K	Sell	5,000 -19	-0.4%	-$721	﹤0.01%	1733
2024 Q4	$197K	Buy	5,019 +19	+0.4%	+$786	﹤0.01%	1662
2024 Q3	$197K	Hold	5,000	–	–	﹤0.01%	1624
2024 Q2	$195K	Hold	5,000	–	–	﹤0.01%	1577
2024 Q1	$215K	Hold	5,000	–	–	﹤0.01%	1530
2023 Q4	$230K	Hold	5,000	–	–	﹤0.01%	1460
2023 Q3	$171K	Hold	5,000	–	–	﹤0.01%	1513
2023 Q2	$193K	Hold	5,000	–	–	﹤0.01%	1476
2023 Q1	$179K	Hold	5,000	–	–	﹤0.01%	1477
2022 Q4	$197K	Buy	+5,000	New	+$182K	﹤0.01%	1423

Other funds holding XENE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Northwestern Mutual Wealth Management's XENE Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Xenon Pharmaceuticals (XENE) position steady in Q2 2026 at 5,000 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #1830.

Northwestern Mutual Wealth Management first reported a position in XENE in Q4 2022 and has held it in 15 quarters since. 196 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Northwestern Mutual Wealth Management held 5,000 shares of Xenon Pharmaceuticals worth $302K as of Q2 2026.
Northwestern Mutual Wealth Management left its Xenon Pharmaceuticals share count unchanged in Q2 2026.
Xenon Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1830 holding.
Northwestern Mutual Wealth Management first reported a position in Xenon Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
196 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.